Zygmunt PM et al. |
Anandamide - the other side of the coin. |
2000 |
Trends Pharmacol. Sci. |
pmid:10664604
|
Jarrahian A et al. |
Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter. |
2000 |
J. Neurochem. |
pmid:10820223
|
Davis JB et al. |
Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. |
2000 |
Nature |
pmid:10821274
|
Zygmunt PM et al. |
The anandamide transport inhibitor AM404 activates vanilloid receptors. |
2000 |
Eur. J. Pharmacol. |
pmid:10822052
|
Maccarrone M et al. |
Anandamide and 2-arachidonoylglycerol inhibit fatty acid amide hydrolase by activating the lipoxygenase pathway of the arachidonate cascade. |
2000 |
Biochem. Biophys. Res. Commun. |
pmid:11095952
|
Calignano A et al. |
A role for the endogenous cannabinoid system in the peripheral control of pain initiation. |
2000 |
Prog. Brain Res. |
pmid:11098711
|
Valk P et al. |
Enhancement of erythropoietin-stimulated cell proliferation by Anandamide correlates with increased activation of the mitogen-activated protein kinases ERK1 and ERK2. |
2000 |
Hematol. J. |
pmid:11920199
|
Di Marzo V et al. |
Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. |
2000 |
J. Neurochem. |
pmid:11080195
|
Rubino T et al. |
Loss of cannabinoid-stimulated guanosine 5'-O-(3-[(35)S]Thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats. |
2000 |
J. Neurochem. |
pmid:11080200
|
Giuffrida A et al. |
Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404. |
2000 |
Eur. J. Pharmacol. |
pmid:11080522
|
Song ZH and Zhong M |
CB1 cannabinoid receptor-mediated cell migration. |
2000 |
J. Pharmacol. Exp. Ther. |
pmid:10871313
|
Tytgat J et al. |
Cannabinoid mimics in chocolate utilized as an argument in court. |
2000 |
Int. J. Legal Med. |
pmid:10876983
|
Andersson M et al. |
Neurotoxicity of glutamate in chick telencephalon neurons: reduction of toxicity by preincubation with carbachol, but not by the endogenous fatty acid amides anandamide and palmitoylethanolamide. |
2000 |
Arch. Toxicol. |
pmid:10877002
|
Maccarrone M et al. |
Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage. |
2000 |
Lancet |
pmid:10776746
|
Houser SJ et al. |
Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide. |
2000 |
Brain Res. |
pmid:10700588
|
Lay L et al. |
Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse. |
2000 |
Eur. J. Pharmacol. |
pmid:10720647
|
Tiger G et al. |
Pharmacological properties of rat brain fatty acid amidohydrolase in different subcellular fractions using palmitoylethanolamide as substrate. |
2000 |
Biochem. Pharmacol. |
pmid:10677581
|
Premkumar LS and Ahern GP |
Induction of vanilloid receptor channel activity by protein kinase C. |
2000 Dec 21-28 |
Nature |
pmid:11140687
|
Hungund BL and Basavarajappa BS |
Are anandamide and cannabinoid receptors involved in ethanol tolerance? A review of the evidence. |
2000 Mar-Apr |
Alcohol Alcohol. |
pmid:10787386
|
Ross RA et al. |
Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens. |
2001 |
Br. J. Pharmacol. |
pmid:11159715
|
Vanheel B and Van de Voorde J |
Regional differences in anandamide- and methanandamide-induced membrane potential changes in rat mesenteric arteries. |
2001 |
J. Pharmacol. Exp. Ther. |
pmid:11160613
|
Ralevic V et al. |
Cannabinoid activation of recombinant and endogenous vanilloid receptors. |
2001 |
Eur. J. Pharmacol. |
pmid:11672565
|
Christopoulos A and Wilson K |
Interaction of anandamide with the M(1) and M(4) muscarinic acetylcholine receptors. |
2001 |
Brain Res. |
pmid:11578621
|
Fowler CJ et al. |
Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide. |
2001 |
Biochem. Pharmacol. |
pmid:11585048
|
Wagner JA et al. |
Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors. |
2001 |
Eur. J. Pharmacol. |
pmid:11448486
|
Boger DL et al. |
alpha-Keto heterocycle inhibitors of fatty acid amide hydrolase: carbonyl group modification and alpha-substitution. |
2001 |
Bioorg. Med. Chem. Lett. |
pmid:11412972
|
Mendizábal VE et al. |
Long-term inhibition of nitric oxide synthase potentiates effects of anandamide in the rat mesenteric bed. |
2001 |
Eur. J. Pharmacol. |
pmid:11567656
|
RodrÃguez de Fonseca F et al. |
An anorexic lipid mediator regulated by feeding. |
2001 |
Nature |
pmid:11700558
|
Jamshidi N and Taylor DA |
Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. |
2001 |
Br. J. Pharmacol. |
pmid:11704633
|
Gurwitz D and Weizman A |
Fatty acid amide hydrolase inhibitors and the marijuana debate. |
2001 |
Lancet |
pmid:11705595
|
Rice AS |
Cannabinoids and pain. |
2001 |
Curr Opin Investig Drugs |
pmid:11575713
|
Karava V et al. |
Anandamide amidohydrolase activity, released in the medium by Tetrahymena pyriformis. Identification and partial characterization. |
2001 |
FEBS Lett. |
pmid:11728445
|
Stamer WD et al. |
Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues. |
2001 |
Eur. J. Pharmacol. |
pmid:11730719
|
Hayase T et al. |
Protective effects of cannabinoid receptor agonists against cocaine and other convulsant-induced toxic behavioural symptoms. |
2001 |
J. Pharm. Pharmacol. |
pmid:11732755
|
Hansen HH et al. |
Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration. |
2001 |
J. Neurochem. |
pmid:11579150
|
Smith PJ and McQueen DS |
Anandamide induces cardiovascular and respiratory reflexes via vasosensory nerves in the anaesthetized rat. |
2001 |
Br. J. Pharmacol. |
pmid:11588121
|
Izzo AA et al. |
The gastrointestinal pharmacology of cannabinoids. |
2001 |
Curr Opin Pharmacol |
pmid:11757815
|
Wagner JA et al. |
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction. |
2001 |
J. Am. Coll. Cardiol. |
pmid:11738314
|
López-RodrÃguez ML et al. |
Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors. |
2001 |
J. Med. Chem. |
pmid:11741470
|
Chemin J et al. |
Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. |
2001 |
EMBO J. |
pmid:11742980
|
Möhle R et al. |
Transendothelial migration of hematopoietic progenitor cells. Role of chemotactic factors. |
2001 |
Ann. N. Y. Acad. Sci. |
pmid:11458515
|
Fride E et al. |
Critical role of the endogenous cannabinoid system in mouse pup suckling and growth. |
2001 |
Eur. J. Pharmacol. |
pmid:11426843
|
Ugdyzhekova DS et al. |
Endogenous cannabinoid anandamide increases heart resistance to arrhythmogenic effects of epinephrine: role of CB(1) and CB(2) receptors. |
2001 |
Bull. Exp. Biol. Med. |
pmid:11427912
|
Murillo-RodrÃguez E et al. |
Anandamide-induced sleep is blocked by SR141716A, a CB1 receptor antagonist and by U73122, a phospholipase C inhibitor. |
2001 |
Neuroreport |
pmid:11447321
|
Sprague J et al. |
Temperature-dependent activation of recombinant rat vanilloid VR1 receptors expressed in HEK293 cells by capsaicin and anandamide. |
2001 |
Eur. J. Pharmacol. |
pmid:11448475
|
Porter AC and Felder CC |
The endocannabinoid nervous system: unique opportunities for therapeutic intervention. |
2001 |
Pharmacol. Ther. |
pmid:11448725
|
Laine K et al. |
Effects of topical anandamide-transport inhibitors, AM404 and olvanil, on intraocular pressure in normotensive rabbits. |
2001 |
Pharm. Res. |
pmid:11451037
|
Holt S et al. |
Effects of pH on the inhibition of fatty acid amidohydrolase by ibuprofen. |
2001 |
Br. J. Pharmacol. |
pmid:11399668
|
Di Marzo V et al. |
Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues. |
2001 |
Eur. J. Pharmacol. |
pmid:11408034
|
Berdyshev EV et al. |
Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells. |
2001 |
FASEB J. |
pmid:11641243
|